pasireotide
pasireotide is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including Signifor, Signifor LAR. Available dosage forms: injection, injection, powder, for suspension, kit.
Drug details
- Generic Name
- pasireotide
- Brand Names
- Signifor, Signifor LAR
- Application Number
- NDA200677
- Sponsor
- Recordati Rare Diseases, Inc.
- NDC Codes
- 13
- Dosage Forms
- INJECTION, INJECTION, POWDER, FOR SUSPENSION, KIT
- Routes
- SUBCUTANEOUS
- Active Ingredients
- PASIREOTIDE
Indications and Usage
1 INDICATIONS AND USAGE SIGNIFOR is a somatostatin analog indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative ( 1 ) 1.1 Cushing's Disease SIGNIFOR is indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.